361 related articles for article (PubMed ID: 25939253)
1. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
Zhou S; Parham DM; Yung E; Pattengale P; Wang L
Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
[TBL] [Abstract][Full Text] [Related]
2. High mobility group AT-hook 2 is overexpressed in hepatoblastoma.
Lee CT; Zhang L; Mounajjed T; Wu TT
Hum Pathol; 2013 May; 44(5):802-10. PubMed ID: 23134771
[TBL] [Abstract][Full Text] [Related]
3. High tricellulin expression is associated with better survival in human hepatoblastoma.
Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
[TBL] [Abstract][Full Text] [Related]
4. Multifocal hepatic neoplasia in 3 children with APC gene mutation.
Gupta A; Sheridan RM; Towbin A; Geller JI; Tiao G; Bove KE
Am J Surg Pathol; 2013 Jul; 37(7):1058-66. PubMed ID: 23715166
[TBL] [Abstract][Full Text] [Related]
5. Hepatic progenitor cells in liver cancers from Asian children.
Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
7. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
Wang FH; Wen JM; Vong HT; Yip YC
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution.
Zhou S; Venkatramani R; Gupta S; Wang K; Stein JE; Wang L; Mascarenhas L
Histopathology; 2017 Nov; 71(5):813-822. PubMed ID: 28660626
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult.
Cho MS; Lee SN; Sung SH; Han WS
Pathol Int; 2004 Jun; 54(6):446-50. PubMed ID: 15144405
[TBL] [Abstract][Full Text] [Related]
10. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.
Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ
Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790
[TBL] [Abstract][Full Text] [Related]
11. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.
Bera G; Das RN; Roy P; Ghosh R; Islam N; Mishra PK; Chatterjee U
Pediatr Surg Int; 2017 Sep; 33(9):961-970. PubMed ID: 28631020
[TBL] [Abstract][Full Text] [Related]
12. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.
Tremosini S; Forner A; Boix L; Vilana R; Bianchi L; Reig M; Rimola J; Rodríguez-Lope C; Ayuso C; Solé M; Bruix J
Gut; 2012 Oct; 61(10):1481-7. PubMed ID: 22287594
[TBL] [Abstract][Full Text] [Related]
13. [Significance of glypican-3 immunohistochemistry in diagnosis of hepatocellular carcinoma].
Yip YC; Wang FH; Vong HT; Zhang M; Wen JM
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):626-9. PubMed ID: 22177248
[TBL] [Abstract][Full Text] [Related]
14. Delta-like protein (DLK) is a novel immunohistochemical marker for human hepatoblastomas.
Dezso K; Halász J; Bisgaard HC; Paku S; Turányi E; Schaff Z; Nagy P
Virchows Arch; 2008 Apr; 452(4):443-8. PubMed ID: 18236070
[TBL] [Abstract][Full Text] [Related]
15. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
Yamauchi N; Watanabe A; Hishinuma M; Ohashi K; Midorikawa Y; Morishita Y; Niki T; Shibahara J; Mori M; Makuuchi M; Hippo Y; Kodama T; Iwanari H; Aburatani H; Fukayama M
Mod Pathol; 2005 Dec; 18(12):1591-8. PubMed ID: 15920546
[TBL] [Abstract][Full Text] [Related]
16. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update.
Ranganathan S; Lopez-Terrada D; Alaggio R
Pediatr Dev Pathol; 2020; 23(2):79-95. PubMed ID: 31554479
[TBL] [Abstract][Full Text] [Related]
17. Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
Abdul-Al HM; Wang G; Makhlouf HR; Goodman ZD
Int J Surg Pathol; 2010 Oct; 18(5):313-8. PubMed ID: 20444731
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of Heat Shock Protein 70, Glypican 3, Glutamine Synthetase, and Beta-Catenin in Hepatocellular Carcinoma After Liver Transplantation: Association Between Positive Glypican 3 and Beta-Catenin With the Presence of Larger Nodules.
Ataide EC; Perales SR; Silva MG; Filho FC; Sparapani AC; Latuf Filho PF; Stucchi RSB; Vassallo J; Escanhoela CAF; Boin IFSF
Transplant Proc; 2017 May; 49(4):858-862. PubMed ID: 28457411
[TBL] [Abstract][Full Text] [Related]
19. Expression of glypican-3 is highly associated with pediatric hepatoblastoma: a systemic analysis.
Xiong XL; Qin H; Yan SQ; Zhou LS; Chen P; Zhao D
Asian Pac J Cancer Prev; 2015; 16(3):1029-31. PubMed ID: 25735325
[TBL] [Abstract][Full Text] [Related]
20. Glypican 3 expression in pediatric malignant solid tumors.
Kinoshita Y; Tanaka S; Souzaki R; Miyoshi K; Kohashi K; Oda Y; Nakatsura T; Taguchi T
Eur J Pediatr Surg; 2015 Feb; 25(1):138-44. PubMed ID: 25344940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
